Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company, Inc. (GCAND) EBITDA (2017 - 2022)

Greater Cannabis Company (GCAND) has 6 years of EBITDA data on record, last reported at -$42267.0 in Q4 2022.

  • For Q4 2022, EBITDA rose 64.81% year-over-year to -$42267.0; the TTM value through Dec 2022 reached -$177035.0, up 48.41%, while the annual FY2024 figure was -$156276.0, 10.88% up from the prior year.
  • EBITDA reached -$42267.0 in Q4 2022 per GCAND's latest filing, up from -$49304.0 in the prior quarter.
  • Across five years, EBITDA topped out at $72562.0 in Q1 2018 and bottomed at -$200627.0 in Q3 2018.
  • Average EBITDA over 5 years is -$79077.4, with a median of -$75253.0 recorded in 2018.
  • The widest YoY moves for EBITDA: up 113.7% in 2018, down 411.22% in 2018.
  • A 5-year view of EBITDA shows it stood at -$76168.0 in 2018, then tumbled by 155.66% to -$194730.0 in 2019, then skyrocketed by 72.51% to -$53532.0 in 2020, then tumbled by 124.36% to -$120102.0 in 2021, then skyrocketed by 64.81% to -$42267.0 in 2022.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$42267.0 in Q4 2022, -$49304.0 in Q3 2022, and -$43034.0 in Q2 2022.